WO2021015289A1 - Composition for maintaining and/or improving memory/learning ability, and food, medicine, and feed containing composition - Google Patents

Composition for maintaining and/or improving memory/learning ability, and food, medicine, and feed containing composition Download PDF

Info

Publication number
WO2021015289A1
WO2021015289A1 PCT/JP2020/028687 JP2020028687W WO2021015289A1 WO 2021015289 A1 WO2021015289 A1 WO 2021015289A1 JP 2020028687 W JP2020028687 W JP 2020028687W WO 2021015289 A1 WO2021015289 A1 WO 2021015289A1
Authority
WO
WIPO (PCT)
Prior art keywords
lactobacillus
strain
memory
learning ability
maintaining
Prior art date
Application number
PCT/JP2020/028687
Other languages
French (fr)
Japanese (ja)
Inventor
聡志 日暮
健太郎 野間
郁恵 森
俊詩 中野
祐基 塚田
Original Assignee
雪印メグミルク株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 雪印メグミルク株式会社 filed Critical 雪印メグミルク株式会社
Publication of WO2021015289A1 publication Critical patent/WO2021015289A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38Other non-alcoholic beverages
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Definitions

  • the present invention provides a preventive / ameliorating agent for deterioration of memory / learning ability that occurs with aging (aging) and / or a preventive / ameliorating effect of deterioration of memory / learning ability that occurs with aging (aging). Regarding food and drink to have.
  • Dementia is a condition in which cognitive function is pathologically impaired due to factors such as cerebral infarction, cerebral hemorrhage, and excessive accumulation of abnormal proteins in addition to these age-related changes.
  • the number of dementia patients is estimated to be about 4.62 million, and the number of people with mild cognitive impairment called the dementia reserve army is estimated to be about 4 million. It is said to be "the age of 8 million people with dementia.”
  • Lactic acid bacteria are widely used in fermented foods such as cheese, yogurt, and pickles, and lactic acid bacteria beverages. They can be supplied at a relatively low cost and have been mass-produced all over the world for a long time due to their high palatability. Recently, it has been attracting attention as a health food having favorable health effects such as prevention of constipation, improvement of diarrhea and other intestinal regulation, prevention of infectious diseases, and immunostimulatory effect.
  • Lactobacillus gasseri and Bifidobacterium longum are effective against age-related metabolic disorders (Patent 5155961, Patent 5155960), Lactobacillus reutery DSM 17938 strain. Is effective for the development of cognitive function in young mammals (Special Table 2015-503913) and the like are disclosed.
  • C. elegans Caenorhabditis elegans can sense various external stimuli and take various response behaviors by using a simple neural circuit consisting of 302 neurons.
  • C. elegans memorizes the breeding temperature as a comfortable temperature when bred at a constant temperature, and therefore shows a habit of moving toward the past breeding temperature when placed on a temperature gradient. For example, C.I. When the elegans are placed on a temperature gradient from 17 ° C to 23 ° C without food, they move to around 23 ° C after 1 hour. Furthermore, C.I.
  • thermotactic behavior is based on a very simple neural circuit (). Nature, 376, 344-348 (1995)).
  • the inventor's research group analyzed the process of temperature memory formation by genome-wide microarray analysis, molecular genetic techniques, and imaging techniques. As a result, C.I. It was found that elegans receives the ambient temperature systemically via the transcription factor HSF-1 when memorizing the breeding temperature.
  • the reception of this temperature causes a change in gene expression, and as a result, the temperature signal is accumulated as a memory in the AFD neuron, which is a temperature receiving neuron of the neural circuit, via the female hormone estrogen. (Nat. Neurosci., 14, 984-92 (2011)).
  • C.I As a result of searching for cells in which orthologs function in elegans, it was found that only one CREB ortholog functions in AFD neurons (EMBO Rep., 12, 855-862 (2011)). That is, C.I. It was shown that among all neurons of elegans, AFD neurons are the only neurons with temperature memory mediated by CREB. These studies reveal some of the molecular mechanisms by which temperature memory is formed.
  • nematodes and mammals are evolutionarily distant, they have much in common in their cellular-level molecular mechanisms. It has been reported that molecules known to be involved in memory in mammals are also involved in the temperature tactics of C. elegans.
  • the memory-related factor CREB (CRH-1 in C. elegans) in mammals is involved in the acquisition of temperature memory in C. elegans (EMBO Rep., 12, 855-862 (2011)), and is involved in memory in C. elegans.
  • Serotonin a transmitter in the brain, controls the temperature motility of nematodes (PLoS One., 8, 1-10 (2013)), and calcineurin, a memory-related factor in mammals (RCAN-1 in nematodes).
  • Has been reported to be involved in the temperature-running behavior of nematodes J. Mol. Biol., 427, 3457-3468 (2015)).
  • thermotactic behavior of elegans is considered to be a model system suitable for analyzing the molecular mechanism of temperature reception and memory.
  • Patent 5155961 Patent 5155960 Special table 2015-503913
  • thermoaxis Quantitative analysis of thermoaxis in the nematode Caenorhabditis elegans. J. Neurosci. Methods, 154, 45-52 (2006) Mori, I., Sasakura, H. & Kuhara, A .: Worm thermoaxis: a model system for analyzing thermosensation and neural plasticity. Curr. Opin. Neurobiol., 17, 712-719 (2007) Mori, I. & Ohshima, Y .: Neural regulation of thermotaxis in Caenorhabditis elegans.
  • the present invention relates to providing a novel lactic acid bacterium having an effect of preventing and / or ameliorating a decrease in memory / learning ability that occurs with aging (aging).
  • the present inventors have focused on the microorganisms used in foods and the components contained therein from the viewpoint of whether various functional abnormalities of the living body can be prevented or ameliorated by the food materials that can be ingested on a daily basis.
  • prevention and prevention of deterioration of memory / learning ability that occurs with aging (aging) in cells or cultures of multiple heterofermentative lactic acid bacteria of the genus Lactobacillus / Or found an action to improve, and completed the present invention. That is, the present invention has the following configuration.
  • a composition for maintaining and / or improving memory / learning ability which comprises cells or cultures of heterofermentative lactic acid bacilli of the genus Lactobacillus.
  • Lactobacillus harbinensis Lactobacillus harbinensis species, Lactobacillus ramnosus species, Lactobacillus casei (Lactobacillus casei) Lactobacillus casei (Lactobacillus lactobacillus)
  • Lactobacillus fermentum Lactobacillus mucosae
  • Lactobacillus reuteri a mixture of these
  • Lactobacillus fermentum Lactobacillus mucosae
  • Lactobacillus reuteri Lactobacillus fermentum, Lactobacillus mucosae, and Lactobacillus reuteri.
  • the composition for maintaining and / or improving memory / learning ability according to (1) which comprises a culture.
  • Heterofermentative Lactobacillus of the genus Lactobacillus is Lactobacillus harbinensis (Lactobacillus harbinensis) species, Lactobacillus ramnosus species, Lactobacillus casei (Lactobacillus casei) Lactobacillus casei (Lactobacillus lactobacillus)
  • the composition for maintaining and / or improving memory / learning ability according to (1) or (2), which does not contain a culture.
  • Heterofermentative lactic acid rods of the genus Lactobacillus are Lactobacillus acidophilus species, Lactobacillus brevis species, Lactobacillus crispatus species, Lactobacillus crispactus species. delbrueckii) species, Lactobacillus Deruburukkyi subspecies Deruburukkyi (Lactobacillus delbruekii subsp.
  • Lactobacillus heterofermentative lactic acid rods are Lactobacillus herbinensis SBT0796 strain, Lactobacillus ramnosus SBT2299 strain, Lactobacillus casei SBT2232 strain, Lactobacillus paracasei SBT0228 strain, Lactobacillus fermentum SBT1859 strain.
  • the memory / learning according to any one of (2) to (4), which comprises one strain of Lactobacillus mucosae SBT2958 strain, one strain of Lactobacillus reutery SBT10010 strain, or a mixture of multiple strains of cells, or a culture. Composition for maintaining and / or improving performance.
  • the decrease in memory / learning ability that occurs with aging (aging) does not include the decrease in memory / learning ability or the decrease in memory ability that occurs with brain disease, memory disorder, and mental illness.
  • (1) to (6) for maintaining and / or improving memory / learning ability for maintaining and / or improving memory / learning ability.
  • composition for maintaining and / or improving memory / learning ability according to any one of (1) to (7), wherein the active ingredient is not a peptide component contained in a culture supernatant of a microorganism but a bacterial cell of the microorganism. .. (9)
  • a food for maintaining and / or improving memory / learning ability which comprises the composition for maintaining / / or improving memory / learning ability according to any one of (1) to (8).
  • Drugs for maintaining and / or improving ability feeds for maintaining and / or improving memory / learning ability.
  • the present invention it is possible to prevent and / or ameliorate the deterioration of memory / learning ability that occurs with aging (aging).
  • aging aging
  • INDUSTRIAL APPLICABILITY The present invention is effective in improving the quality of life of elderly people who are concerned about deterioration of memory / learning ability.
  • C It is a figure which showed the outline of the temperature taxis test using elegans.
  • C. It is a figure which showed the change of the memory index with aging of elegans and the memory index of the aging adult who ingested lactic acid bacteria. It is a figure which showed the relationship between the phylogenetic tree of lactic acid bacteria and the memory index of the aging adult which ingested lactic acid bacteria. It is a figure which compared the memory index of the aging adult which ingested lactic acid bacterium by the difference in the fermentation form of lactic acid bacterium.
  • the term "maintaining and / or improving memory / learning ability” preferably means preventing and / or ameliorating the deterioration of memory / learning ability that occurs with aging (aging). More preferably, it means preventing and / or ameliorating the deterioration of memory ability that occurs with aging (aging). Furthermore, in the present specification, when “decrease in memory / learning ability that occurs with aging (aging)” or “decrease in memory ability that occurs with aging (aging)” is preferably referred to as Alzheimer's disease.
  • Dementia such as Huntington's disease and cerebral basal nucleus disease such as Parkinson's disease, and memory disorders such as amnesia, memory loss, and Korsakov syndrome, as well as depression, anxiety, bipolar disorder, integration. Does not include memory / learning or memory loss associated with mental disorders such as dementia, sleep abnormalities, and stress disorders.
  • composition preferably means a pharmaceutical composition or a food composition.
  • the lactic acid bacterium in the present invention is characterized by using a heterofermentative lactic acid bacillus belonging to the genus Lactobacillus.
  • a heterofermentative lactic acid rod bacteria belonging to the genus Lactobacillus Lactobacillus habinensis species, Lactobacillus ramnosus species, Lactobacillus casei species, Lactobacillus paracasei species, Lactobacillus fermentum species, Lactobacillus mucosae species, Lactobacillus reutery species are preferred.
  • Lactobacillus harbinensis SBT0796 Lactobacillus ramnosus SBT2299, Lactobacillus casei SBT2232, Lactobacillus paracasei SBT0228, Lactobacillus fermentum SBT1859, Lactobacillus mucosae SBT2958.
  • Reutery SBT10010 strain it is not particularly limited as long as it is a heterofermentative lactic acid bacterium having an effect of maintaining and / or improving the memory / learning ability of the present invention.
  • heterofermentative lactic acid bacilli may be used alone or in combination of two or more lactic acid bacteria as appropriate.
  • these heterofermentative lactic acid bacilli can be cultivated according to a conventional method for culturing lactic acid bacteria.
  • the culture medium various media such as a milk medium, a medium containing a milk component, and a semi-synthetic medium not containing the milk component can be used. Examples of such a medium include a reduced skim milk medium and an MRS medium.
  • the cells separated from the obtained culture by means of collecting bacteria such as centrifugation can be used as they are as the active ingredient of the present invention.
  • Bacterial cells that have been concentrated, dried, freeze-dried, etc. can be used, or can be killed by heat-drying or the like.
  • Not only purely isolated cells, but also cultures, suspensions, other cell-containing substances, and cytoplasm and cell wall fractions obtained by treating cells using enzymes or physical means can be used. It can.
  • the form of the culture is not only a culture using a medium generally used for culturing lactic acid bacteria such as a synthetic medium MRS medium (manufactured by DIFCO) and a reduced defatted milk medium, but also cheese, fermented milk, and milk. Products Dairy products such as lactic acid bacteria beverages can be exemplified, but are not particularly limited.
  • the excipients, stabilizers, flavoring agents, etc. permitted in the formulation are appropriately mixed, concentrated, freeze-dried, and heat-dried. It may be a dead cell. These dried products, concentrates and pastes are also contained.
  • it is an excipient, a binder, a disintegrant, a lubricant, a flavoring agent, and a suspending agent.
  • Coating agents, and any other drug can be mixed and formulated.
  • the dosage form can be tablets, capsules, granules, powders, powders, syrups, etc., and it is desirable to administer these orally.
  • the composition for maintaining and / or improving the memory / learning ability of the present invention may be blended in any food or drink, or may be added to a raw material during the manufacturing process of the food or drink.
  • foods and drinks include cheese, fermented milk, dairy products, lactic acid bacteria beverages, lactic acid bacteria beverages, butter, dairy products such as margarine, beverages such as dairy beverages, fruit juice beverages, and soft beverages, and eggs such as jelly, candy, pudding, and mayonnaise.
  • Processed products, sweets and breads such as butter cakes, various milk powders, infant foods, nutritional compositions, etc. can be mentioned, but are not particularly limited.
  • the composition for maintaining and / or improving the memory / learning ability of the present invention can be added to the feed. Like the food and drink, it may be blended with any feed and may be added to the raw material during the feed manufacturing process.
  • the blending ratio of the cells or cultures of heterofermentative lactic acid bacilli belonging to the genus Lactobacillus is not particularly limited, and the ease of production and It may be appropriately adjusted according to a preferable daily dose. It is determined individually in consideration of the symptoms, age, etc.
  • the blending amount may be adjusted so that 5,000 mg can be ingested. By ingesting in this way, a desired effect can be exhibited.
  • C.I as a method for screening for lactic acid bacteria that prevent and / or improve the deterioration of memory / learning ability that occurs with aging (aging), C.I.
  • a temperature taxis test using elegans was used.
  • higher animals such as mice, rats, dogs, and monkeys are used to verify the physiological functions of food components and drugs, but this requires a great deal of labor, time, and cost, and is ethical. It is necessary to give due consideration to.
  • tests using cultured cells isolated from animal tissues are also being conducted.
  • C. C. elegans is a non-parasitic multicellular organism that lives in soil, and in addition to being easy to handle as an experimental animal, the cell lineage of about 1000 somatic cells that make up the body has been clarified. It is widely used in various research fields as a model organism because it has points and a nervous system. In particular, he has made great contributions in various research fields such as cell death, neurogenesis, development, and aging. Furthermore, in recent years, C.I., a model of various neurodegenerative diseases such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Huntington's disease. Using elegans, the search for effective medicines and food components for the prevention and improvement of these neurodegenerative diseases is underway.
  • ALS amyotrophic lateral sclerosis
  • Huntington's disease Using elegans, the search for effective medicines and food components for the prevention and improvement of these neurodegenerative diseases is underway.
  • elegans Although elegans has a simple neural circuit, it is known to memorize and learn by associating information such as the presence or absence of food with the salt concentration and temperature in the environment placed at that time, such as associative learning and memory. It can be used as a model system for evaluating the cognitive function of (Nature, 376, 344-348 (1995)).
  • Test Example 1 Evaluation of lactic acid bacteria that prevent and / or improve the deterioration of memory / learning ability that occurs with aging (aging)
  • C.I. Elegans used a wild-type N2 strain and was bred according to the "Nematode Lab Manual”.
  • Test Method (1) Test Bacteria Strains of heterofermentative lactic acid bacilli belonging to the genus Lactobacillus shown in Table 1 were subjected to screening.
  • test procedure (i) Preparation of evaluation sample Each test bacterium of (1) above was inoculated into MRS medium and statically cultured at 37 ° C. for 16 hours. The cultured cells were centrifuged (7,000 ⁇ g, 4 ° C., 15 minutes), and the supernatant was discarded. After washing the cells with physiological saline, the wet weight of the cells was determined, and NG buffer (0.3% NaCl, 1 mM CaCl 2 , 1 mM sulfonyl 4 , 25 mM phosphate buffer) was adjusted to 0.05 g / ml. Resuspended in [pH 6.0]) and C.I.
  • a sample plate was prepared by sowing 200 ⁇ l each on an elegans breeding plate (NGM plate).
  • NNM plate elegans breeding plate
  • C.I. Escherichia coli OP50 strain which is generally used as a diet for elegans, was used.
  • An agar plate placed in a square petri dish is placed on an aluminum table so that the temperature is centered at 20 ° C., and the above-mentioned young adults or aged adults are released in the center of the plate, and one hour later, C.I.
  • the distribution of elegans was evaluated.
  • the memory / learning ability was determined by C.I., which was located in two compartments near the breeding temperature (23 ° C.) when the plate was divided into eight equal parts in the temperature gradient direction.
  • the proportion of elegans was evaluated as a memory index (FIG. 1).
  • the presence or absence of a significant difference when an aged adult who ingested OP50 was used as a control was evaluated by a Danette-type multiple test (p ⁇ 0.05 was judged to be significant).
  • FIG. 2 shows the screening results.
  • the memory index decreased in the aged adults compared to the young adults.
  • Aged adults who ingested the Lactobacillus reutery SBT10010 strain had a significantly increased memory index compared to those who ingested OP50. That is, it was found that by ingesting the above-mentioned cells, it is possible to prevent and / or improve the deterioration of memory / learning ability that occurs with aging (aging).
  • the results of the memory index of nematodes that ingested lactic acid bacteria were applied to a phylogenetic tree created based on the 16s rRNA sequence of lactic acid bacteria, and it was verified whether there was a correlation between the strain of lactic acid bacteria and the memory index.
  • the tendency of the memory index value differs among the clusters of the phylogenetic tree, and it belongs to the genus Lactobacillus as compared with the homofermentative strains belonging to the genus Lactobacillus and the strains belonging to the genus Leuconostoc and the genus Bifidobacterium.
  • Heterofermentative strains showed high values (Figs. 3 and 4). It was shown that the components produced by heterofermentative lactic acid bacteria may improve the temperature memory of C. elegans.
  • Example 1 Production of agent (granule) for maintaining and / or improving memory / learning ability Lactobacillus reutery SBT10010 strain edible synthetic medium (0.5% yeast extract, 0.1% trypticase soybean peptone addition) ) Was ingested in an amount of 5% by weight, cultured at 38 ° C. for 15 hours, and then the cells were collected by centrifugation. The recovered cells were freeze-dried to obtain a freeze-dried powder of the early cells. 1 g of this freeze-dried powder was mixed with 5 g of lactose and molded into granules to obtain an agent for maintaining and / or improving the memory / learning ability of the present invention.
  • Example 2 Manufacture of agent (powder) for maintaining and / or improving memory / learning ability
  • agent (powder) for maintaining and / or improving memory / learning ability
  • -400 g of lactose (Japanese Pharmacopoeia) and 600 g of potato starch (Japanese Pharmacopoeia) were added to 10 g of lyophilized powder of Reutery SBT10010 strain and mixed uniformly to produce an agent for maintaining and / or improving memory / learning ability of the present invention.
  • Example 3 Production of nutritional composition for maintaining and / or improving memory / learning ability A synthetic medium in which Lactobacillus reutery SBT10010 strain is edible (0.5% yeast extract, 0.1% trypticase soybean peptone added) After ingesting 5% by weight and culturing at 37 ° C. for 15 hours, the cells were collected by centrifugation, and the collected cells were lyophilized. To 40 g of vitamin C or an equal amount mixture of vitamin C and citric acid, 100 g of granulated sugar, and 60 g of an equal amount mixture of cornstarch and lactose, 40 g of the freeze-dried powder of this freeze-dried powder was added and mixed. The mixture was packed in a bag to produce a nutritional composition for maintaining and / or improving memory / learning ability of the present invention.
  • Example 4 Production of beverage for maintaining and / or improving memory / learning ability After 1 g of Lactobacillus reutery SBT10010 strain obtained in Example 3 above was dissolved in 699 g of deionized water and then heated to 40 ° C. The mixture was stirred and mixed at 9,500 rpm for 20 minutes with an ultra disperser (ULTRA-TURRAX T-25; manufactured by IKA Japan). After adding 100 g of maltitol, 2 g of acidulant, 20 g of reduced starch syrup, 2 g of flavor and 176 g of deionized water, the mixture is filled in a 100 ml glass bottle, sterilized at 95 ° C. for 15 seconds, and then sealed to maintain the memory / learning ability of the present invention. And / or 10 bottles of improving beverage (containing 100 ml) were produced.
  • Example 5 Production of feed for maintaining and / or improving memory / learning ability Soybean meal 12 kg, skim milk powder 14 kg, soybean oil 4 kg, corn oil 2 kg, palm oil 23.2 kg, corn starch 14 kg, wheat flour 9 kg, bran 2 kg, 5 kg of vitamin mixture, 2.8 kg of cellulose, and 2 kg of mineral mixture were blended, sterilized at 120 ° C. for 4 minutes, and 10 kg of lactobacillus reutery SBT10010 strain obtained in Example 3 was blended to store and learn the present invention. A feed for maintaining and / or improving performance was produced.
  • Example 6 Production of fermented milk for maintaining and / or improving memory / learning ability A synthetic medium in which Bifidobacterium reutery SBT10010 strain is edible (0.5% yeast extract, 0.1% trypticase soybean peptone addition) ) was ingested in an amount of 5% by weight, cultured at 37 ° C. for 17 hours, and then the cells were collected by centrifugation and lyophilized. 5 g of the lyophilized cells, 1700 g of skim milk powder, 300 g of glucose, and 7695 g of deionized water were mixed and kept at 95 ° C. for 2 hours for heat sterilization.
  • Lactobacillus harbinensis SBT0796 shares (receipt number: NITE ABP-02993, receipt date: July 13, 2020, original contract date: June 26, 2019), contractor: Chiba, Japan 292-0818 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
  • Lactobacillus ramnosus SBT2299 shares (receipt number: NITE ABP-02994, receipt date: July 13, 2020, original contract date: June 26, 2019), contractor: Chiba, Japan 292-0818 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
  • Lactobacillus casei SBT2232 shares (trust number: NITE P-02995, trust date: June 26, 2019), trustee: 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, Japan 292-0818 , National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
  • Lactobacillus fermentum SBT1859 shares (trust number: NITE P-02996, trust date: June 26, 2019), trustee: 2-5 Kazusakamatari, Kisarazu City, Chiba Prefecture, Japan 292-0818 8. National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
  • Lactobacillus reutery SBT10010 shares (receipt number: NITE ABP-02997, receipt date: July 13, 2020, original contract date: June 26, 2019), contractor: ⁇ 292-0818 Chiba, Japan 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Husbandry (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)

Abstract

To provide a medicine or a food and drink and a feed which are effective in preventing and/or ameliorating memory/learning ability deterioration due to aging. Provided is a novel lactic acid bacterium having the effect of preventing and/or ameliorating memory/learning ability deterioration due to aging. Specifically, the lactic acid bacterium belongs to the heterofermentative Lactobacillus genus. More specifically, the lactic acid bacterium is characterized by being a lactic acid bacterium belonging to any of the Lactobacillus harbinensis species, Lactobacillus rhamnosus species, Lactobacillus casei species, Lactobacillus paracasei species, Lactobacillus fermentum species, Lactobacillus mucosae species, and Lactobacillus reuteri species.

Description

記憶・学習能維持および/または向上用組成物及び組成物を含む食品、医薬品、飼料Compositions for maintaining and / or improving memory / learning ability and foods, medicines, feeds containing the compositions
本発明は、加齢(老化)に伴って発生する記憶・学習能の低下の予防・改善剤および/または加齢(老化)に伴って発生する記憶・学習能の低下の予防・改善作用を有する飲食品に関する。 The present invention provides a preventive / ameliorating agent for deterioration of memory / learning ability that occurs with aging (aging) and / or a preventive / ameliorating effect of deterioration of memory / learning ability that occurs with aging (aging). Regarding food and drink to have.
わが国は2010年に65歳以上の高齢者人口が全人口の21%を突破し超高齢社会へと突入した。高齢者の割合は今後も増加していくことが予想されており、2060年には40%に達するとされている。このような状況の中で、医療、福祉など増加する高齢人口の問題に対応することが喫緊の課題となっている。 In 2010, the elderly population aged 65 and over exceeded 21% of the total population, and Japan entered a super-aging society. The proportion of elderly people is expected to continue to increase, reaching 40% by 2060. Under such circumstances, it is an urgent issue to deal with the problems of the increasing elderly population such as medical care and welfare.
高齢人口の増加に伴い、中高年層の記憶・学習能の低下などの認知機能障害や認知症の増加が問題視されている。一般的に、加齢に伴い脳の神経細胞の微細構造に変化が起こり、異常タンパク質の沈着や細胞の脱落を経て、脳が萎縮していくことにより、認知機能が低下していくと考えられている。これらの加齢変化に加えて、脳梗塞や脳出血、異常タンパク質の過剰な蓄積などの要因が加わり、認知機能が病的に低下した状態が認知症である。 With the increase in the elderly population, the increase in cognitive dysfunction and dementia such as deterioration of memory and learning ability of middle-aged and elderly people is regarded as a problem. In general, it is thought that the microstructure of nerve cells in the brain changes with aging, and cognitive function declines as the brain atrophies through abnormal protein deposition and cell shedding. ing. Dementia is a condition in which cognitive function is pathologically impaired due to factors such as cerebral infarction, cerebral hemorrhage, and excessive accumulation of abnormal proteins in addition to these age-related changes.
2012年時点で65歳以上の高齢者のうち、認知症患者は推計15%にあたる約462万人、認知症予備軍と呼ばれる軽度認知障害者は約400万人に上るとされ、現在の日本は「認知症800万人時代」といわれている。 As of 2012, among the elderly aged 65 and over, the number of dementia patients is estimated to be about 4.62 million, and the number of people with mild cognitive impairment called the dementia reserve army is estimated to be about 4 million. It is said to be "the age of 8 million people with dementia."
認知症に対する治療薬の開発が進められているが、現時点では進行を遅らせることを目的として使用されるものであり、根本的な治療には至っていない。一方、健常な高齢者や認知症の前駆状態として位置付けられている軽度認知障害の高齢者においては、食生活の見直しや運動など適切な介入を行うことにより、記憶・学習能などの認知機能の低下を予防または改善、さらには認知症発症リスクを低減できる可能性が示されている(精神経誌 111, 26-30, (2009))。このことから、日々の生活の中で継続して摂取することができ、かつ安全性が高く副作用のない飲食物への関心が高まっている。 Development of therapeutic agents for dementia is underway, but at present, it is used for the purpose of delaying the progression, and has not yet reached a radical treatment. On the other hand, in healthy elderly people and elderly people with mild cognitive impairment, which is positioned as a precursor of dementia, cognitive functions such as memory and learning ability can be improved by reviewing dietary habits and performing appropriate interventions such as exercise. It has been shown that the decline can be prevented or ameliorated, and the risk of developing dementia can be reduced (Seino Journal 111, 26-30, (2009)). For this reason, there is increasing interest in foods and drinks that can be continuously ingested in daily life, are safe, and have no side effects.
乳酸菌は、チーズやヨーグルト、漬物などの発酵食品や乳酸菌飲料など多岐にわたり利用されており、比較的安価に供給できる上、その高い嗜好性から世界中で古くから大量に生産されている。最近では、便秘防止、下痢改善などの整腸作用、感染症の予防、免疫賦活作用など、健康上好ましい保健効果も有する健康食品として注目されている。老化や認知機能に関連したものでは、ラクトバチルス・ガセリやビフィドバクテリウム・ロングムが加齢に伴う代謝異常に対して有効であること(特許5155961、特許5155960)、ラクトバチルス・ロイテリー DSM 17938株が幼若哺乳動物の認知機能の発達に有効であること(特表2015-503913)などが開示されている。 Lactic acid bacteria are widely used in fermented foods such as cheese, yogurt, and pickles, and lactic acid bacteria beverages. They can be supplied at a relatively low cost and have been mass-produced all over the world for a long time due to their high palatability. Recently, it has been attracting attention as a health food having favorable health effects such as prevention of constipation, improvement of diarrhea and other intestinal regulation, prevention of infectious diseases, and immunostimulatory effect. Regarding aging and cognitive function, Lactobacillus gasseri and Bifidobacterium longum are effective against age-related metabolic disorders (Patent 5155961, Patent 5155960), Lactobacillus reutery DSM 17938 strain. Is effective for the development of cognitive function in young mammals (Special Table 2015-503913) and the like are disclosed.
しかしながら、加齢に伴って発生する記憶・学習能の低下に対するラクトバチルス属に属するヘテロ発酵型乳酸桿菌の作用については、未だ明らかでない。 However, the action of heterofermentative lactic acid bacilli belonging to the genus Lactobacillus on the decline in memory and learning ability that occurs with aging is still unclear.
線虫Caenorhabditis elegans(以下、C. elegansとする)は、302個のニューロンからなるシンプルな神経回路を用いて、様々な外部刺激を感知し、多様な応答行動をとることができる。線虫は、一定の温度で飼育されるとその飼育温度を快適な温度として記憶するため、温度勾配の上におくと過去の飼育温度へ向かうという習性を示す。例えば、23℃で飼育されたC. elegansは餌のない17℃から23℃までの温度勾配の上におかれた場合、1時間後には23℃付近へと移動する。さらに、23℃を記憶していたC. elegansを新たな温度である17℃で飼育すると、約4時間で新たな温度17℃の記憶を獲得し、温度勾配の上で17℃付近へと移動するようになる(Proc. Natl. Acad. Sci. USA, 72, 4061-4065 (1975); Genetics, 169, 1437-1450 (2005); J. Neurosci. Methods, 154, 45-52 (2006))。この習性は温度走性とよばれ、記憶や学習といった神経機能の可塑性を反映したすぐれたモデル系であることが知られる(Curr. Opin. Neurobiol., 17, 712-719 (2007))。 C. elegans Caenorhabditis elegans (hereinafter referred to as C. elegans) can sense various external stimuli and take various response behaviors by using a simple neural circuit consisting of 302 neurons. C. elegans memorizes the breeding temperature as a comfortable temperature when bred at a constant temperature, and therefore shows a habit of moving toward the past breeding temperature when placed on a temperature gradient. For example, C.I. When the elegans are placed on a temperature gradient from 17 ° C to 23 ° C without food, they move to around 23 ° C after 1 hour. Furthermore, C.I. When elegans are bred at a new temperature of 17 ° C, they acquire a memory of a new temperature of 17 ° C in about 4 hours and move to around 17 ° C on a temperature gradient (Proc. Natl. Acad. Sci. USA, 72, 4061-4065 (1975); Genetics, 169, 1437-1450 (2005); J. Neurosci. Methods, 154, 45-52 (2006)). This habit is called temperature tactics and is known to be an excellent model system that reflects the plasticity of neural functions such as memory and learning (Curr. Opin. Neurobiol., 17, 712-719 (2007)).
発明者らの過去のレーザーによるニューロンの破壊実験から、温度走性行動に必要なニューロンが明らかにされており、温度走性行動はきわめてシンプルな神経回路を基盤とすることが知られている(Nature, 376, 344-348 (1995))。また、発明者らの研究グループは、温度記憶が形成される過程をゲノムワイドなマイクロアレイ解析、分子遺伝学的な手法とイメージング技術により解析した。その結果、C. elegansは飼育温度を記憶する際に、転写因子であるHSF-1を介して周囲の温度を全身で受容していることを見い出した。さらに、この温度の受容は遺伝子の発現変化をひき起こし、その結果、温度シグナルは女性ホルモンであるエストロゲンを介して神経回路の温度受容ニューロンであるAFDニューロンに記憶として蓄積されることが示された(Nat. Neurosci., 14, 984-92 (2011))。 The inventors' past experiments on neuron destruction by laser have revealed the neurons required for thermotactic behavior, and it is known that thermotactic behavior is based on a very simple neural circuit (). Nature, 376, 344-348 (1995)). In addition, the inventor's research group analyzed the process of temperature memory formation by genome-wide microarray analysis, molecular genetic techniques, and imaging techniques. As a result, C.I. It was found that elegans receives the ambient temperature systemically via the transcription factor HSF-1 when memorizing the breeding temperature. Furthermore, it was shown that the reception of this temperature causes a change in gene expression, and as a result, the temperature signal is accumulated as a memory in the AFD neuron, which is a temperature receiving neuron of the neural circuit, via the female hormone estrogen. (Nat. Neurosci., 14, 984-92 (2011)).
更に、発明者らは、記憶を担う代表的な転写因子CREBのC. elegansにおけるオルソログの機能する細胞を探索した結果、CREBのオルソログはたった一つ、AFDニューロンでのみ機能することを見い出している(EMBO Rep., 12, 855-862 (2011))。つまり、C. elegansのすべてのニューロンのなかでも、AFDニューロンはCREBを介した温度記憶をもつ唯一のニューロンであることが示された。これらの研究から、温度記憶が形成される際の分子機構の一端が明らかになっている。 Furthermore, the inventors have described the C.I. As a result of searching for cells in which orthologs function in elegans, it was found that only one CREB ortholog functions in AFD neurons (EMBO Rep., 12, 855-862 (2011)). That is, C.I. It was shown that among all neurons of elegans, AFD neurons are the only neurons with temperature memory mediated by CREB. These studies reveal some of the molecular mechanisms by which temperature memory is formed.
線虫と哺乳動物は進化系統上離れているものの、細胞レベルの分子機構は共通する部分が大きい。哺乳動物において記憶に関わることが知られている分子が線虫の温度走性にも関与することが報告されている。例えば、哺乳類で記憶に関わる因子CREB(線虫ではCRH-1)は、線虫の温度記憶の獲得に関与すること(EMBO Rep., 12, 855-862 (2011))、哺乳類で記憶に関わる脳内伝達物質であるセロトニンは、線虫の温度走性を制御していること(PLoS One., 8, 1-10 (2013))、哺乳類で記憶に関わる因子カルシニューリン(線虫ではRCAN-1)は、線虫の温度走性行動に関わること(J. Mol. Biol., 427, 3457-3468 (2015))など多数の報告がされている。 Although nematodes and mammals are evolutionarily distant, they have much in common in their cellular-level molecular mechanisms. It has been reported that molecules known to be involved in memory in mammals are also involved in the temperature tactics of C. elegans. For example, the memory-related factor CREB (CRH-1 in C. elegans) in mammals is involved in the acquisition of temperature memory in C. elegans (EMBO Rep., 12, 855-862 (2011)), and is involved in memory in C. elegans. Serotonin, a transmitter in the brain, controls the temperature motility of nematodes (PLoS One., 8, 1-10 (2013)), and calcineurin, a memory-related factor in mammals (RCAN-1 in nematodes). ) Has been reported to be involved in the temperature-running behavior of nematodes (J. Mol. Biol., 427, 3457-3468 (2015)).
更に、線虫で神経系に対する有効性が認められる成分が、哺乳動物においても脳・神経系に対する効果を示す事例が報告されている。即ち、経口摂取したαリポ酸は、加齢で低下した線虫及び哺乳動物の連合学習行動を改善すること(Neurobiol. Aging., 26, 899-905 (2005); J. Med. Food. 15, 713-7 (2012))、経口摂取したクルクミンは、線虫及び哺乳動物において、加齢に伴う認知障害を改善すること(Neurobiol. Aging., 39, 69-81 (2016); Geroscience., 40, 73-95 (2018))などが報告されている。 Furthermore, there have been reports of cases in which a component that has been shown to be effective against the nervous system in nematodes also has an effect on the brain and nervous system in mammals. That is, orally ingested α-lipoic acid improves the associative learning behavior of age-related nematodes and mammals (Neurobiol. Aging., 26, 899-905 (2005); J. Med. Food. 15 , 713-7 (2012)), Orally ingested curcumin improves age-related cognitive impairment in nematodes and mammals (Neurobiol. Aging., 39, 69-81 (2016); Geroscience., 40, 73-95 (2018)) etc. have been reported.
これらのことから、C. elegansの温度走性行動は温度の受容と記憶の分子機構を解析することに適したモデル系と考えられている。 From these things, C.I. The thermotactic behavior of elegans is considered to be a model system suitable for analyzing the molecular mechanism of temperature reception and memory.
特許5155961Patent 5155961 特許5155960Patent 5155960 特表2015-503913Special table 2015-503913
本発明は、加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善する効果を有する新規乳酸菌を提供することに関する。 The present invention relates to providing a novel lactic acid bacterium having an effect of preventing and / or ameliorating a decrease in memory / learning ability that occurs with aging (aging).
本発明者らは、日常的に摂取が可能である食品素材によって、生体の種々の機能異常を予防や改善できないかという観点で、食品に使用される微生物およびそれに含まれる成分に着目し、上記課題を解決すべく鋭意研究を重ねた結果、ラクトバチルス属の複数のヘテロ発酵型乳酸桿菌の菌体または培養物に、加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善する作用を見出し、本発明を完成するに至った。即ち、本発明は、下記の構成を有する。
(1)ラクトバチルス属のヘテロ発酵型乳酸桿菌の菌体または培養物を含む記憶・学習能維持および/または向上用組成物。
(2)ラクトバチルス属のヘテロ発酵型乳酸桿菌が、ラクトバチルス・ハービネンシス(Lactobacillus harbinensis)種、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)種、ラクトバチルス・カゼイ(Lactobacillus casei)種、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)種、ラクトバチルス・ファーメンタム(Lactobacillus fermentum)種、ラクトバチルス・ムコーサエ(Lactobacillus mucosae)種、ラクトバチルス・ロイテリー(Lactobacillus reuteri)種の1種もしくはそれらを複数種の菌体を混合したもの、または培養物を含む(1)に記載の記憶・学習能維持および/または向上用組成物。
(3)ラクトバチルス属のヘテロ発酵型乳酸桿菌が、ラクトバチルス・ハービネンシス(Lactobacillus harbinensis)種、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)種、ラクトバチルス・カゼイ(Lactobacillus casei)種、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)種、ラクトバチルス・ファーメンタム(Lactobacillus fermentum)種、ラクトバチルス・ムコーサエ(Lactobacillus mucosae)種、ラクトバチルス・ロイテリー(Lactobacillus reuteri)種の1種もしくはそれらを複数種の菌体を混合したもの、または培養物を含まない(1)または(2)に記載の記憶・学習能維持および/または向上用組成物。
(4)ラクトバチルス属のヘテロ発酵型乳酸桿菌が、ラクトバチルス・アシドフィルス(Lactobacillus acidophilus)種、ラクトバチルス・ブレビス(Lactobacillus brevis)種、ラクトバチルス・クリスパタス(Lactobacillus crispatus)種、ラクトバチルス・デルブルッキィ(Lactobacillus delbrueckii)種、ラクトバチルス・デルブルッキィ亜種デルブルッキィ(Lactobacillus delbruekii subsp. delbruekii)種、ラクトバチルス・ガセリ(Lactobacillus gasseri)種、ラクトバチルス・ヘルベティカス(Lactobacillus helveticus)種、ラクトバチルス・ジョンソニィ(Lactobacillus johnsonii)種、ラクトバチルス・ラクチス(Lactobacillus lactis)種、ラクトバチルス・ライヒマニ(Lactobacillus leichmannii)種、ラクトバチルス・ペントーサス(Lactobacillus pentosus)種、ラクトバチルス・プランタルム(Lactobacillus plantarum)種、ラクトバチルス・サケイ(Lactobacillus sakei)種、ラクトバチルス・サリバリウス(Lactobacillus salivarius)種の1種もしくはそれらを複数種の菌体を混合したもの、または培養物を含まない(1)から(3)のいずれかに記載の記憶・学習能維持および/または向上用組成物。
(5)ラクトバチルス属のヘテロ発酵型乳酸桿菌が、ラクトバチルス・ハービネンシスSBT0796株、ラクトバチルス・ラムノーサスSBT2299株、ラクトバチルス・カゼイSBT2232株、ラクトバチルス・パラカゼイSBT0228株、ラクトバチルス・ファーメンタムSBT1859株、ラクトバチルス・ムコーサエSBT2958株、ラクトバチルス・ロイテリーSBT10010株の1株もしくはそれらを複数株の菌体を混合したもの、または培養物を含む(2)から(4)のいずれかに記載の記憶・学習能維持および/または向上用組成物。
(6)前記記憶・学習能維持および/または向上が、加齢(老化)に伴って発生する記憶・学習能の低下の予防および/または改善である、(1)から(5)のいずれかに記載の記憶・学習能維持および/または向上用組成物。
(7)前記加齢(老化)に伴って発生する記憶・学習能の低下が、脳疾患、記憶障害、及び精神疾患に伴って発生する記憶・学習能の低下あるいは記憶能の低下を含まない、(1)から(6)のいずれかに記載の記憶・学習能維持および/または向上用組成物。
(8)微生物の培養上清に含まれるペプチド成分ではなく微生物の菌体を有効成分とする、(1)から(7)のいずれかに記載の記憶・学習能維持および/または向上用組成物。
(9)(1)から(8)のいずれかに記載の記憶・学習能維持および/または向上用組成物を含むことを特徴とする記憶・学習能維持および/または向上用食品、記憶・学習能維持および/または向上用医薬品、記憶・学習能維持および/または向上用飼料。
(10)受託番号がNITE BP-02993であるラクトバチルス・ハービネンシスSBT0796株、受託番号がNITE BP-02994であるラクトバチルス・ラムノーサスSBT2299株、受託番号がNITE P-02995であるラクトバチルス・カゼイSBT2232株、受託番号がNITE P-02996であるラクトバチルス・ファーメンタムSBT1859株、又は受託番号がNITE BP-02997であるラクトバチルス・ロイテリーSBT10010株。
The present inventors have focused on the microorganisms used in foods and the components contained therein from the viewpoint of whether various functional abnormalities of the living body can be prevented or ameliorated by the food materials that can be ingested on a daily basis. As a result of intensive research to solve the problems, prevention and prevention of deterioration of memory / learning ability that occurs with aging (aging) in cells or cultures of multiple heterofermentative lactic acid bacteria of the genus Lactobacillus / Or found an action to improve, and completed the present invention. That is, the present invention has the following configuration.
(1) A composition for maintaining and / or improving memory / learning ability, which comprises cells or cultures of heterofermentative lactic acid bacilli of the genus Lactobacillus.
(2) Heterofermentative Lactobacillus of the genus Lactobacillus is Lactobacillus harbinensis (Lactobacillus harbinensis) species, Lactobacillus ramnosus species, Lactobacillus casei (Lactobacillus casei) Lactobacillus casei (Lactobacillus lactobacillus) One or more of Lactobacillus fermentum, Lactobacillus mucosae, Lactobacillus reuteri, a mixture of these, and Lactobacillus fermentum, Lactobacillus mucosae, and Lactobacillus reuteri. Alternatively, the composition for maintaining and / or improving memory / learning ability according to (1), which comprises a culture.
(3) Heterofermentative Lactobacillus of the genus Lactobacillus is Lactobacillus harbinensis (Lactobacillus harbinensis) species, Lactobacillus ramnosus species, Lactobacillus casei (Lactobacillus casei) Lactobacillus casei (Lactobacillus lactobacillus) One or more of Lactobacillus fermentum, Lactobacillus mucosae, Lactobacillus reuteri, a mixture of these, and Lactobacillus fermentum, Lactobacillus mucosae, and Lactobacillus reuteri. Alternatively, the composition for maintaining and / or improving memory / learning ability according to (1) or (2), which does not contain a culture.
(4) Heterofermentative lactic acid rods of the genus Lactobacillus are Lactobacillus acidophilus species, Lactobacillus brevis species, Lactobacillus crispatus species, Lactobacillus crispactus species. delbrueckii) species, Lactobacillus Deruburukkyi subspecies Deruburukkyi (Lactobacillus delbruekii subsp. delbruekii) species, Lactobacillus gasseri (Lactobacillus gasseri) species, Lactobacillus helveticus (Lactobacillus helveticus) species, Lactobacillus Jonsonyi (Lactobacillus johnsonii) species, Lactobacillus lactis, Lactobacillus leichmannii, Lactobacillus pentosus, Lactobacillus lactobacillus lactobacillus lactobacillus lactobacillus lactobacillus The memory / learning ability maintenance and memory / learning ability maintenance according to any one of (1) to (3), which is one of Lactobacillus salivalius species or a mixture of a plurality of types of cells, or does not contain a culture. / Or an improving composition.
(5) Lactobacillus heterofermentative lactic acid rods are Lactobacillus herbinensis SBT0796 strain, Lactobacillus ramnosus SBT2299 strain, Lactobacillus casei SBT2232 strain, Lactobacillus paracasei SBT0228 strain, Lactobacillus fermentum SBT1859 strain. The memory / learning according to any one of (2) to (4), which comprises one strain of Lactobacillus mucosae SBT2958 strain, one strain of Lactobacillus reutery SBT10010 strain, or a mixture of multiple strains of cells, or a culture. Composition for maintaining and / or improving performance.
(6) Any of (1) to (5), wherein the maintenance and / or improvement of the memory / learning ability is prevention and / or improvement of the deterioration of the memory / learning ability that occurs with aging (aging). The composition for maintaining and / or improving memory / learning ability according to.
(7) The decrease in memory / learning ability that occurs with aging (aging) does not include the decrease in memory / learning ability or the decrease in memory ability that occurs with brain disease, memory disorder, and mental illness. , (1) to (6) for maintaining and / or improving memory / learning ability.
(8) The composition for maintaining and / or improving memory / learning ability according to any one of (1) to (7), wherein the active ingredient is not a peptide component contained in a culture supernatant of a microorganism but a bacterial cell of the microorganism. ..
(9) A food for maintaining and / or improving memory / learning ability, which comprises the composition for maintaining / / or improving memory / learning ability according to any one of (1) to (8). Drugs for maintaining and / or improving ability, feeds for maintaining and / or improving memory / learning ability.
(10) Lactobacillus harbinensis SBT0796 strain with a trust number of NITE BP-02993, Lactobacillus ramnosus SBT2299 strain with a trust number of NITE BP-02994, and Lactobacillus casei SBT2232 strain with a trust number of NITE P-02995. , Lactobacillus fermentum SBT1859 strain with a trust number of NITE P-02996, or Lactobacillus reutery SBT10010 strain with a trust number of NITE BP-02997.
本発明によれば、加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善することができる。本発明は、記憶・学習能の低下が気になる高齢者の、日常生活における生活の質(Quality of life)の向上に有効である。 According to the present invention, it is possible to prevent and / or ameliorate the deterioration of memory / learning ability that occurs with aging (aging). INDUSTRIAL APPLICABILITY The present invention is effective in improving the quality of life of elderly people who are concerned about deterioration of memory / learning ability.
C.elegansを用いた温度走性試験の概要を示した図である。C. It is a figure which showed the outline of the temperature taxis test using elegans. C.elegansの加齢に伴う記憶指数の変化および乳酸菌を摂取した加齢成虫の記憶指数を示した図である。C. It is a figure which showed the change of the memory index with aging of elegans and the memory index of the aging adult who ingested lactic acid bacteria. 乳酸菌の系統樹と乳酸菌を摂取した加齢成虫の記憶指数との関連を示した図である。It is a figure which showed the relationship between the phylogenetic tree of lactic acid bacteria and the memory index of the aging adult which ingested lactic acid bacteria. 乳酸菌を摂取した加齢成虫の記憶指数を乳酸菌の発酵形態の違いで比較した図である。It is a figure which compared the memory index of the aging adult which ingested lactic acid bacterium by the difference in the fermentation form of lactic acid bacterium.
本明細書で「記憶・学習能維持および/または向上」というときは、好ましくは、加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善することを意味し、より好ましくは、加齢(老化)に伴って発生する記憶能の低下を予防および/または改善することを意味する。更に、本明細書で「加齢(老化)に伴って発生する記憶・学習能の低下」あるいは「加齢(老化)に伴って発生する記憶能の低下」というときは、好ましくは、アルツハイマー病やハンチントン病などの認知症およびパーキンソン病などの大脳基底核疾患を含む脳疾患、並びに、健忘症、記憶喪失、およびコルサコフ症候群などの記憶障害、並びに、うつ病、不安症、双極性障害、統合失調症、睡眠異常、およびストレス障害などの精神疾患伴って発生する記憶・学習能の低下あるいは記憶能の低下を含まない。 In the present specification, the term "maintaining and / or improving memory / learning ability" preferably means preventing and / or ameliorating the deterioration of memory / learning ability that occurs with aging (aging). More preferably, it means preventing and / or ameliorating the deterioration of memory ability that occurs with aging (aging). Furthermore, in the present specification, when "decrease in memory / learning ability that occurs with aging (aging)" or "decrease in memory ability that occurs with aging (aging)" is preferably referred to as Alzheimer's disease. Dementia such as Huntington's disease and cerebral basal nucleus disease such as Parkinson's disease, and memory disorders such as amnesia, memory loss, and Korsakov syndrome, as well as depression, anxiety, bipolar disorder, integration. Does not include memory / learning or memory loss associated with mental disorders such as dementia, sleep abnormalities, and stress disorders.
本明細書で「組成物」というときは、好ましくは、医薬組成物、または、食品組成物を意味する。 The term "composition" as used herein preferably means a pharmaceutical composition or a food composition.
本発明における乳酸菌としては、ラクトバチルス属に属するヘテロ発酵型乳酸桿菌を用いることを特徴とする。ラクトバチルス属に属するヘテロ発酵型乳酸桿菌としては、ラクトバチルス・ハービネンシス種、ラクトバチルス・ラムノーサス種、ラクトバチルス・カゼイ種、ラクトバチルス・パラカゼイ種、ラクトバチルス・ファーメンタム種、ラクトバチルス・ムコーサエ種、ラクトバチルス・ロイテリー種が好ましい。更に好ましいのはラクトバチルス・ハービネンシスSBT0796株、ラクトバチルス・ラムノーサスSBT2299株、ラクトバチルス・カゼイSBT2232株、ラクトバチルス・パラカゼイSBT0228株、ラクトバチルス・ファーメンタムSBT1859株、ラクトバチルス・ムコーサエSBT2958株、ラクトバチルス・ロイテリーSBT10010株であるが、本発明の記憶・学習能を維持および/または向上する効果を有するヘテロ発酵型乳酸桿菌であれば特に限定されるものではない。 The lactic acid bacterium in the present invention is characterized by using a heterofermentative lactic acid bacillus belonging to the genus Lactobacillus. As heterofermentative lactic acid rod bacteria belonging to the genus Lactobacillus, Lactobacillus habinensis species, Lactobacillus ramnosus species, Lactobacillus casei species, Lactobacillus paracasei species, Lactobacillus fermentum species, Lactobacillus mucosae species, Lactobacillus reutery species are preferred. More preferred are Lactobacillus harbinensis SBT0796, Lactobacillus ramnosus SBT2299, Lactobacillus casei SBT2232, Lactobacillus paracasei SBT0228, Lactobacillus fermentum SBT1859, Lactobacillus mucosae SBT2958. Although it is the Reutery SBT10010 strain, it is not particularly limited as long as it is a heterofermentative lactic acid bacterium having an effect of maintaining and / or improving the memory / learning ability of the present invention.
これらのヘテロ発酵型乳酸桿菌は、単独で用いる事もできるし、適宜2つ以上の乳酸菌を組み合わせて用いてもよい。また、これらのヘテロ発酵型乳酸桿菌は、乳酸菌培養の常法に従って培養することができる。培養培地には、乳培地又は乳成分を含む培地、これを含まない半合成培地など種々の培地を用いることができる。このような培地としては、還元脱脂乳培地やMRS培地などを例示することができる。 These heterofermentative lactic acid bacilli may be used alone or in combination of two or more lactic acid bacteria as appropriate. In addition, these heterofermentative lactic acid bacilli can be cultivated according to a conventional method for culturing lactic acid bacteria. As the culture medium, various media such as a milk medium, a medium containing a milk component, and a semi-synthetic medium not containing the milk component can be used. Examples of such a medium include a reduced skim milk medium and an MRS medium.
得られた培養物から遠心分離などの集菌手段によって分離された菌体をそのまま本発明の有効成分として用いることができる。濃縮、乾燥、凍結乾燥などした菌体を用いることもできるし、加熱乾燥などにより死菌体にしてもよい。菌体として純粋に分離されたものだけでなく、培養物、懸濁物、その他の菌体含有物や、菌体を酵素や物理的手段を用いて処理した細胞質や細胞壁画分も用いることができる。培養物などの形態としては、合成培地であるMRS培地(DIFCO社製)、還元脱脂乳培地など一般的に乳酸菌の培養に用いられる培地を用いた培養物だけでなく、チーズ、発酵乳、乳製品乳酸菌飲料などの乳製品などを例示することができるが特に限定されるものではない。 The cells separated from the obtained culture by means of collecting bacteria such as centrifugation can be used as they are as the active ingredient of the present invention. Bacterial cells that have been concentrated, dried, freeze-dried, etc. can be used, or can be killed by heat-drying or the like. Not only purely isolated cells, but also cultures, suspensions, other cell-containing substances, and cytoplasm and cell wall fractions obtained by treating cells using enzymes or physical means can be used. it can. The form of the culture is not only a culture using a medium generally used for culturing lactic acid bacteria such as a synthetic medium MRS medium (manufactured by DIFCO) and a reduced defatted milk medium, but also cheese, fermented milk, and milk. Products Dairy products such as lactic acid bacteria beverages can be exemplified, but are not particularly limited.
本発明の記憶・学習能維持および/または向上剤の製剤化に際しては、製剤上許可されている賦型剤、安定剤、矯味剤などを適宜混合して濃縮、凍結乾燥するほか、加熱乾燥して死菌体にしてもよい。これらの乾燥物、濃縮物、ペースト状物も含有される。また、ラクトバチルス属に属するヘテロ発酵型乳酸桿菌の記憶・学習能維持および/または向上作用を妨げない範囲で、賦型剤、結合剤、崩壊剤、滑沢剤、矯味矯臭剤、懸濁剤、コーティング剤、その他の任意の薬剤を混合して製剤化することもできる。剤形としては、錠剤、カプセル剤、顆粒剤、散剤、粉剤、シロップ剤などが可能であり、これらを経口的に投与することが望ましい。 In formulating the memory / learning ability maintaining and / or improving agent of the present invention, the excipients, stabilizers, flavoring agents, etc. permitted in the formulation are appropriately mixed, concentrated, freeze-dried, and heat-dried. It may be a dead cell. These dried products, concentrates and pastes are also contained. In addition, as long as it does not interfere with the memory / learning ability maintenance and / or improving action of the heterofermentative lactic acid bacillus belonging to the genus Lactobacillus, it is an excipient, a binder, a disintegrant, a lubricant, a flavoring agent, and a suspending agent. , Coating agents, and any other drug can be mixed and formulated. The dosage form can be tablets, capsules, granules, powders, powders, syrups, etc., and it is desirable to administer these orally.
本発明の記憶・学習能維持および/または向上用組成物はどのような飲食品に配合しても良く、飲食品の製造工程中に原料に添加しても良い。飲食品の例としては、チーズ、発酵乳、乳製品乳酸菌飲料、乳酸菌飲料、バター、マーガリンなどの乳製品、乳飲料、果汁飲料、清涼飲料などの飲料、ゼリー、キャンディー、プリン、マヨネーズなどの卵加工品、バターケーキなどの菓子・パン類、さらには、各種粉乳の他、乳幼児食品、栄養組成物などを挙げることができるが特に限定されるものではない。さらに、本発明の記憶・学習能維持および/または向上用組成物を飼料に配合することができる。前記飲食品と同様にどのような飼料に配合しても良く、飼料の製造工程中に原料に添加しても良い。 The composition for maintaining and / or improving the memory / learning ability of the present invention may be blended in any food or drink, or may be added to a raw material during the manufacturing process of the food or drink. Examples of foods and drinks include cheese, fermented milk, dairy products, lactic acid bacteria beverages, lactic acid bacteria beverages, butter, dairy products such as margarine, beverages such as dairy beverages, fruit juice beverages, and soft beverages, and eggs such as jelly, candy, pudding, and mayonnaise. Processed products, sweets and breads such as butter cakes, various milk powders, infant foods, nutritional compositions, etc. can be mentioned, but are not particularly limited. Further, the composition for maintaining and / or improving the memory / learning ability of the present invention can be added to the feed. Like the food and drink, it may be blended with any feed and may be added to the raw material during the feed manufacturing process.
ラクトバチルス属に属するヘテロ発酵型乳酸桿菌の菌体又は培養物を配合して、記憶・学習能維持および/または向上用組成物あるいは、記憶・学習能維持および/または向上用飲食品、栄養組成物、飼料などの素材又はそれら素材の加工品に配合させて使用する場合、ラクトバチルス属に属するヘテロ発酵型乳酸桿菌の菌体または培養物の配合割合は特に限定されず、製造の容易性や好ましい一日投与量にあわせて適宜調節すればよい。投与対象者の症状、年齢などを考慮してそれぞれ個別に決定されるが、通常成人の場合、例えば、ラクトバチルス・ラムノーサスの培養物などを10~200g、あるいはその菌体自体を0.1~5,000mg摂取できるように配合量などを調整すればよい。このようにして摂取することにより所望の効果を発揮することができる。 A composition for maintaining and / or improving memory / learning ability, or a food / drink or nutritional composition for maintaining and / or improving memory / learning ability by blending cells or cultures of heterofermentative lactic acid bacilli belonging to the genus Lactobacillus. When used by blending with materials such as products and feeds or processed products of those materials, the blending ratio of the cells or cultures of heterofermentative lactic acid bacilli belonging to the genus Lactobacillus is not particularly limited, and the ease of production and It may be appropriately adjusted according to a preferable daily dose. It is determined individually in consideration of the symptoms, age, etc. of the recipient, but in the case of adults, for example, 10 to 200 g of a culture of Lactobacillus ramnosus, or 0.1 to the bacterial cells themselves. The blending amount may be adjusted so that 5,000 mg can be ingested. By ingesting in this way, a desired effect can be exhibited.
本発明における、加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善する乳酸菌をスクリーニングする方法として、C.elegansを用いた温度走性試験を用いた。一般的に、食成分や薬剤の生理機能を検証する際には、マウスやラット、イヌ、サルなどの高等動物が用いられるが、それには多大な労力や時間、費用を要する上に、倫理面に十分に配慮する必要がある。動物実験の代替法として、動物の組織から分離した培養細胞などを用いた試験も行われている。 In the present invention, as a method for screening for lactic acid bacteria that prevent and / or improve the deterioration of memory / learning ability that occurs with aging (aging), C.I. A temperature taxis test using elegans was used. Generally, higher animals such as mice, rats, dogs, and monkeys are used to verify the physiological functions of food components and drugs, but this requires a great deal of labor, time, and cost, and is ethical. It is necessary to give due consideration to. As an alternative method for animal experiments, tests using cultured cells isolated from animal tissues are also being conducted.
C.elegansは土壌中に生息する非寄生性の多細胞生物であり、実験動物としての取り扱いが容易である点に加え、体を構成する約1000個の体細胞の細胞系譜がすべて明らかになっている点や神経系を有するなどといった点から、モデル生物として様々な研究分野で広く利用されている。特に、細胞死、神経、発生、老化等の様々な研究分野において多大な貢献を果たしてきた。さらに、近年では、アルツハイマー病や筋委縮性側索硬化症(ALS)、パーキンソン病、ハンチントン病など様々な神経変性疾患モデルのC.elegansを用いて、これらの神経変性疾患の予防や改善に有効な医薬品や食成分の探索が進められている。 C. C. elegans is a non-parasitic multicellular organism that lives in soil, and in addition to being easy to handle as an experimental animal, the cell lineage of about 1000 somatic cells that make up the body has been clarified. It is widely used in various research fields as a model organism because it has points and a nervous system. In particular, he has made great contributions in various research fields such as cell death, neurogenesis, development, and aging. Furthermore, in recent years, C.I., a model of various neurodegenerative diseases such as Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and Huntington's disease. Using elegans, the search for effective medicines and food components for the prevention and improvement of these neurodegenerative diseases is underway.
C.elegansは単純な神経回路を有しながらも、食餌の有無とその際に置かれた環境における塩濃度や温度などの情報を関連付けて記憶・学習することが知られており、連合学習や記憶などの認知機能を評価するモデル系として活用することができる(Nature, 376, 344-348 (1995))。 C. Although elegans has a simple neural circuit, it is known to memorize and learn by associating information such as the presence or absence of food with the salt concentration and temperature in the environment placed at that time, such as associative learning and memory. It can be used as a model system for evaluating the cognitive function of (Nature, 376, 344-348 (1995)).
以下、本発明について実施例をもとにさらに詳細に説明するが、本発明は係る実施例に限定して解釈されるものではない。 Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not construed as being limited to such examples.
[試験例1]加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善する乳酸菌の評価
本明細書で用いるC.elegansは野生型であるN2株を用い、「線虫ラボマニュアル」に従って飼育した。
1.試験方法
(1)供試菌
表1に示したラクトバチルス属に属するヘテロ発酵型乳酸桿菌の菌株をスクリーニングに供した。
[Test Example 1] Evaluation of lactic acid bacteria that prevent and / or improve the deterioration of memory / learning ability that occurs with aging (aging) C.I. Elegans used a wild-type N2 strain and was bred according to the "Nematode Lab Manual".
1. 1. Test Method (1) Test Bacteria Strains of heterofermentative lactic acid bacilli belonging to the genus Lactobacillus shown in Table 1 were subjected to screening.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
(2)試験手順
(i) 評価サンプルの準備
上記(1)の各供試菌をMRS培地に植菌し、37℃にて16時間静置培養を行った。培養菌体を遠心分離(7,000×g、4℃、15分)し、上清を廃棄した。菌体は生理食塩水で洗浄した後、菌体の湿重量を求め、0.05g/mlになるようにNGバッファー(0.3% NaCl、1mM CaCl、1mM MgSO、25mMリン酸緩衝液[pH6.0])に再懸濁し、C.elegans飼育用プレート(NGMプレート)に200μlずつ播種したものをサンプルプレートとした。コントロールとして、C.elegansの食餌として一般的に用いられている大腸菌OP50株を用いた。
(2) Test procedure
(i) Preparation of evaluation sample Each test bacterium of (1) above was inoculated into MRS medium and statically cultured at 37 ° C. for 16 hours. The cultured cells were centrifuged (7,000 × g, 4 ° C., 15 minutes), and the supernatant was discarded. After washing the cells with physiological saline, the wet weight of the cells was determined, and NG buffer (0.3% NaCl, 1 mM CaCl 2 , 1 mM sulfonyl 4 , 25 mM phosphate buffer) was adjusted to 0.05 g / ml. Resuspended in [pH 6.0]) and C.I. A sample plate was prepared by sowing 200 μl each on an elegans breeding plate (NGM plate). As a control, C.I. Escherichia coli OP50 strain, which is generally used as a diet for elegans, was used.
(ii) 乳酸菌を摂取した加齢成虫の準備
ブリーチ処理により回収したC.elegansの卵を、OP50を播種したプレートに播き、23℃で3日間静置し、若齢成虫を得た。この成虫をNGバッファーで回収し、乳酸菌を播種したプレートもしくはOP50を播種したプレートに移し、23℃で4日間飼育し、加齢成虫を得た。
(ii) Preparation of aging adults ingested with lactic acid bacteria C. recovered by bleaching. Eggs of elegans were sown on a plate in which OP50 was sown and allowed to stand at 23 ° C. for 3 days to obtain young adults. The adults were collected with NG buffer, transferred to a plate in which lactic acid bacteria were sown or a plate in which OP50 was sown, and bred at 23 ° C. for 4 days to obtain aging adults.
(iii) 温度走性試験によるスクリーニング
温度走性試験は、Ito H.ら(J. Neurosci. Methods, 154, 45-52 (2006))に記載の方法に従い以下の通り実施した。二つの恒温槽を準備し、コの字型のアルミ台(21.5cm×60cm×1.5cm厚)の片方の足を低温側(5℃)に、もう片方を高温側(35℃)の恒温槽に浸すことで、アルミ台におよそ5℃から35℃までの直線状温度勾配を形成した。角型シャーレに入れた寒天プレートを20℃が中心となるようにアルミ台の上に置き、上述した若齢成虫もしくは加齢成虫をプレートの中央に放ち、一時間後の温度勾配上のC.elegansの分布を評価した。記憶・学習能は、プレートを温度勾配方向に8等分したときの飼育温度(23℃)近辺の2区画に位置したC.elegansの割合を記憶指数(Memory index)として評価した(図1)。また、ダネット型多重検定により、OP50を摂取した加齢成虫を対照としたときの有意差の有無を評価した(p<0.05を有意差ありと判定した)。
(iii) Screening by temperature taxis test The temperature taxis test is performed by Ito H. et al. (J. Neurosci. Methods, 154, 45-52 (2006)) et al. (J. Neurosci. Methods, 154, 45-52 (2006)). Prepare two constant temperature baths, one foot of the U-shaped aluminum stand (21.5 cm x 60 cm x 1.5 cm thick) on the low temperature side (5 ° C) and the other on the high temperature side (35 ° C). By immersing in a constant temperature bath, a linear temperature gradient from about 5 ° C. to 35 ° C. was formed on the aluminum table. An agar plate placed in a square petri dish is placed on an aluminum table so that the temperature is centered at 20 ° C., and the above-mentioned young adults or aged adults are released in the center of the plate, and one hour later, C.I. The distribution of elegans was evaluated. The memory / learning ability was determined by C.I., which was located in two compartments near the breeding temperature (23 ° C.) when the plate was divided into eight equal parts in the temperature gradient direction. The proportion of elegans was evaluated as a memory index (FIG. 1). In addition, the presence or absence of a significant difference when an aged adult who ingested OP50 was used as a control was evaluated by a Danette-type multiple test (p <0.05 was judged to be significant).
2.試験結果 
図2にスクリーニング結果を示す。若齢成虫に比べて加齢成虫で記憶指数が低下した。ヘテロ発酵型乳酸桿菌であるラクトバチルス・ハービネンシスSBT0796株、ラクトバチルス・ラムノーサスSBT2299株、ラクトバチルス・カゼイSBT2232株、ラクトバチルス・パラカゼイSBT0228株、ラクトバチルス・ファーメンタムSBT1859株、ラクトバチルス・ムコーサエSBT2958株、ラクトバチルス・ロイテリーSBT10010株を摂取した加齢成虫ではOP50を摂取したものと比べて記憶指数が有意に増加した。すなわち、上記菌体を摂取することにより、加齢(老化)に伴って発生する記憶・学習能の低下を予防および/または改善させることができることがわかった
2. 2. Test results
FIG. 2 shows the screening results. The memory index decreased in the aged adults compared to the young adults. Lactobacillus harbinensis SBT0796 strain, Lactobacillus ramnosus SBT2299 strain, Lactobacillus casei SBT2232 strain, Lactobacillus paracasei SBT0228 strain, Lactobacillus fermentum SBT1859 strain, Lactobacillus fermentum SBT1859 strain, which are heterofermentative lactic acid rods. Aged adults who ingested the Lactobacillus reutery SBT10010 strain had a significantly increased memory index compared to those who ingested OP50. That is, it was found that by ingesting the above-mentioned cells, it is possible to prevent and / or improve the deterioration of memory / learning ability that occurs with aging (aging).
乳酸菌を摂取した線虫の記憶指数の結果を乳酸菌の16s rRNA配列を基にして作成した系統樹に当てはめ、乳酸菌の系統と記憶指数との間に相関関係があるか否かを検証した。その結果、系統樹のクラスターで記憶指数の値の傾向が異なり、ラクトバチルス属に属するホモ発酵型の菌株並びにロイコノストック属やビフィドバクテリウム属に属する菌株と比べて、ラクトバチルス属に属するヘテロ発酵型の菌株で高値を示した(図3、4)。ヘテロ発酵型の乳酸菌が産生する成分が線虫の温度記憶を向上させる可能性が示された。 The results of the memory index of nematodes that ingested lactic acid bacteria were applied to a phylogenetic tree created based on the 16s rRNA sequence of lactic acid bacteria, and it was verified whether there was a correlation between the strain of lactic acid bacteria and the memory index. As a result, the tendency of the memory index value differs among the clusters of the phylogenetic tree, and it belongs to the genus Lactobacillus as compared with the homofermentative strains belonging to the genus Lactobacillus and the strains belonging to the genus Leuconostoc and the genus Bifidobacterium. Heterofermentative strains showed high values (Figs. 3 and 4). It was shown that the components produced by heterofermentative lactic acid bacteria may improve the temperature memory of C. elegans.
(実施例1)記憶・学習能維持および/または向上用剤(顆粒)の製造
ラクトバチルス・ロイテリーSBT10010株を食用可能な合成培地(0.5%酵母エキス、0.1%トリプチケースペプトン添加)に5重量%摂取し、38℃で15時間培養後、遠心分離で菌体を回収した。回収した菌体を凍結乾燥し、前期菌体の凍結乾燥粉末を得た。この凍結乾燥粉末1gを乳糖5gと混合し、顆粒状に成形して本発明の記憶・学習能維持および/または向上用剤を得た。
(Example 1) Production of agent (granule) for maintaining and / or improving memory / learning ability Lactobacillus reutery SBT10010 strain edible synthetic medium (0.5% yeast extract, 0.1% trypticase soybean peptone addition) ) Was ingested in an amount of 5% by weight, cultured at 38 ° C. for 15 hours, and then the cells were collected by centrifugation. The recovered cells were freeze-dried to obtain a freeze-dried powder of the early cells. 1 g of this freeze-dried powder was mixed with 5 g of lactose and molded into granules to obtain an agent for maintaining and / or improving the memory / learning ability of the present invention.
(実施例2)記憶・学習能維持および/または向上用剤(散剤)の製造
第13改正日本薬局方解説書製剤総則「散剤」の規定に準拠し、上記実施例1で得られたラクトバチルス・ロイテリーSBT10010株の凍結乾燥粉末10gに乳糖(日局)400g、バレイショデンプン(日局)600gを加えて均一に混合し、本発明の記憶・学習能維持および/または向上用剤を製造した。
(Example 2) Manufacture of agent (powder) for maintaining and / or improving memory / learning ability The lactobacillus obtained in Example 1 above in accordance with the provisions of the 13th revised Japanese Pharmacopoeia Manual of Formulation "Powder". -400 g of lactose (Japanese Pharmacopoeia) and 600 g of potato starch (Japanese Pharmacopoeia) were added to 10 g of lyophilized powder of Reutery SBT10010 strain and mixed uniformly to produce an agent for maintaining and / or improving memory / learning ability of the present invention.
(実施例3)記憶・学習能維持および/または向上用栄養組成物の製造
ラクトバチルス・ロイテリーSBT10010株を食用可能な合成培地(0.5%酵母エキス、0.1%トリプチケースペプトン添加)に5重量%摂取し、37℃で15時間培養後、遠心分離で菌体を回収し、回収した菌体を凍結乾燥した。ビタミンC40gまたはビタミンCとクエン酸の等量混合物40g、グラニュー糖100g、コーンスターチと乳糖の等量混合物60gに、この凍結乾燥粉末の凍結乾燥粉末40gを加えて混合した。混合物を袋に詰め、本発明の記憶・学習能維持および/または向上用栄養組成物を製造した。
(Example 3) Production of nutritional composition for maintaining and / or improving memory / learning ability A synthetic medium in which Lactobacillus reutery SBT10010 strain is edible (0.5% yeast extract, 0.1% trypticase soybean peptone added) After ingesting 5% by weight and culturing at 37 ° C. for 15 hours, the cells were collected by centrifugation, and the collected cells were lyophilized. To 40 g of vitamin C or an equal amount mixture of vitamin C and citric acid, 100 g of granulated sugar, and 60 g of an equal amount mixture of cornstarch and lactose, 40 g of the freeze-dried powder of this freeze-dried powder was added and mixed. The mixture was packed in a bag to produce a nutritional composition for maintaining and / or improving memory / learning ability of the present invention.
(実施例4)記憶・学習能維持および/または向上用飲料の製造
上記実施例3で得られたラクトバチルス・ロイテリーSBT10010株1gを699gの脱イオン水に溶解した後、40℃まで加熱後、ウルトラディスパーサー(ULTRA-TURRAX T-25;IKAジャパン社製)にて、9,500rpmで20分間撹拌混合した。マルチトール100g、酸味料2g、還元水飴20g、香料2g、脱イオン水176gを添加した後、100mlのガラス瓶に充填し、95℃、15秒間殺菌後、密栓し、本発明の記憶・学習能維持および/または向上用飲料10本(100ml入り)を製造した。
(Example 4) Production of beverage for maintaining and / or improving memory / learning ability After 1 g of Lactobacillus reutery SBT10010 strain obtained in Example 3 above was dissolved in 699 g of deionized water and then heated to 40 ° C. The mixture was stirred and mixed at 9,500 rpm for 20 minutes with an ultra disperser (ULTRA-TURRAX T-25; manufactured by IKA Japan). After adding 100 g of maltitol, 2 g of acidulant, 20 g of reduced starch syrup, 2 g of flavor and 176 g of deionized water, the mixture is filled in a 100 ml glass bottle, sterilized at 95 ° C. for 15 seconds, and then sealed to maintain the memory / learning ability of the present invention. And / or 10 bottles of improving beverage (containing 100 ml) were produced.
(実施例5)記憶・学習能維持および/または向上用飼料の製造
大豆粕12kg、脱脂粉乳14kg、大豆油4kg、コーン油2kg、パーム油23.2kg、トウモロコシ澱粉14kg、小麦粉9kg、ふすま2kg、ビタミン混合物5kg、セルロース2.8kg、ミネラル混合物2kgを配合し、120℃、4分間殺菌して、実施例3で得られたラクトバチルス・ロイテリーSBT10010株10kgを配合して、本発明の記憶・学習能維持および/または向上用飼料を製造した。
(Example 5) Production of feed for maintaining and / or improving memory / learning ability Soybean meal 12 kg, skim milk powder 14 kg, soybean oil 4 kg, corn oil 2 kg, palm oil 23.2 kg, corn starch 14 kg, wheat flour 9 kg, bran 2 kg, 5 kg of vitamin mixture, 2.8 kg of cellulose, and 2 kg of mineral mixture were blended, sterilized at 120 ° C. for 4 minutes, and 10 kg of lactobacillus reutery SBT10010 strain obtained in Example 3 was blended to store and learn the present invention. A feed for maintaining and / or improving performance was produced.
(実施例6)記憶・学習能維持および/または向上用発酵乳の製造
ビフィドバクテリウム・ロイテリーSBT10010株を食用可能な合成培地(0.5%酵母エキス、0.1%トリプチケースペプトン添加)に5重量%摂取し、37℃で17時間培養後、遠心分離で菌体を回収し、凍結乾燥した。この凍結乾燥菌体5g、脱脂粉乳1700g、グルコース300g、脱イオン水7695gを混合し、95℃で2時間保持することで加熱殺菌した。これを37℃まで冷却し、乳酸菌スターター(Lb.casei)を300g植菌し、撹拌混合後、37℃に保持したインキュベーター内でpH4.0まで発酵させた。pH4.0到達後、10℃以下まで冷却し、本発明の記憶・学習能維持および/または向上用発酵乳10kgを製造した。
(Example 6) Production of fermented milk for maintaining and / or improving memory / learning ability A synthetic medium in which Bifidobacterium reutery SBT10010 strain is edible (0.5% yeast extract, 0.1% trypticase soybean peptone addition) ) Was ingested in an amount of 5% by weight, cultured at 37 ° C. for 17 hours, and then the cells were collected by centrifugation and lyophilized. 5 g of the lyophilized cells, 1700 g of skim milk powder, 300 g of glucose, and 7695 g of deionized water were mixed and kept at 95 ° C. for 2 hours for heat sterilization. This was cooled to 37 ° C., 300 g of a lactic acid bacterium starter (Lb. Casei) was inoculated, stirred and mixed, and then fermented to pH 4.0 in an incubator maintained at 37 ° C. After reaching pH 4.0, the mixture was cooled to 10 ° C. or lower to produce 10 kg of fermented milk for maintaining and / or improving the memory / learning ability of the present invention.
(1)ラクトバチルス・ハービネンシスSBT0796株(受領番号:NITE ABP-02993、受領日:2020年7月13日、原受託日:2019年6月26日)、受託先:〒292-0818 日本国千葉県木更津市かずさ鎌足2-5-8、独立行政法人 製品評価技術基盤機構 特許微生物寄託センター(NPMD)。
(2)ラクトバチルス・ラムノーサスSBT2299株(受領番号:NITE ABP-02994、受領日:2020年7月13日、原受託日:2019年6月26日)、受託先:〒292-0818 日本国千葉県木更津市かずさ鎌足2-5-8、独立行政法人 製品評価技術基盤機構 特許微生物寄託センター(NPMD)。
(3)ラクトバチルス・カゼイSBT2232株(受託番号:NITE P-02995、受託日:2019年6月26日)、受託先:〒292-0818 日本国千葉県木更津市かずさ鎌足2-5-8、独立行政法人 製品評価技術基盤機構 特許微生物寄託センター(NPMD)。
(4)ラクトバチルス・ファーメンタムSBT1859株(受託番号:NITE P-02996、受託日:2019年6月26日)、受託先:〒292-0818 日本国千葉県木更津市かずさ鎌足2-5-8、独立行政法人 製品評価技術基盤機構 特許微生物寄託センター(NPMD)。
(5)ラクトバチルス・ロイテリーSBT10010株(受領番号:NITE ABP-02997、受領日:2020年7月13日、原受託日:2019年6月26日)、受託先:〒292-0818 日本国千葉県木更津市かずさ鎌足2-5-8、独立行政法人 製品評価技術基盤機構 特許微生物寄託センター(NPMD)。
(1) Lactobacillus harbinensis SBT0796 shares (receipt number: NITE ABP-02993, receipt date: July 13, 2020, original contract date: June 26, 2019), contractor: Chiba, Japan 292-0818 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
(2) Lactobacillus ramnosus SBT2299 shares (receipt number: NITE ABP-02994, receipt date: July 13, 2020, original contract date: June 26, 2019), contractor: Chiba, Japan 292-0818 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
(3) Lactobacillus casei SBT2232 shares (trust number: NITE P-02995, trust date: June 26, 2019), trustee: 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, Japan 292-0818 , National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
(4) Lactobacillus fermentum SBT1859 shares (trust number: NITE P-02996, trust date: June 26, 2019), trustee: 2-5 Kazusakamatari, Kisarazu City, Chiba Prefecture, Japan 292-0818 8. National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).
(5) Lactobacillus reutery SBT10010 shares (receipt number: NITE ABP-02997, receipt date: July 13, 2020, original contract date: June 26, 2019), contractor: 〒292-0818 Chiba, Japan 2-5-8 Kazusakamatari, Kisarazu City, Chiba Prefecture, National Institute of Technology and Evaluation Patent Microorganisms Depositary Center (NPMD).

Claims (5)

  1. ラクトバチルス属のヘテロ発酵型乳酸桿菌の菌体または培養物を含む記憶・学習能維持および/または向上用組成物。 A composition for maintaining and / or improving memory / learning ability, which comprises cells or cultures of a heterofermentative lactic acid bacillus of the genus Lactobacillus.
  2. ラクトバチルス属のヘテロ発酵型乳酸桿菌が、ラクトバチルス・ハービネンシス(Lactobacillus harbinensis)種、ラクトバチルス・ラムノーサス(Lactobacillus rhamnosus)種、ラクトバチルス・カゼイ(Lactobacillus casei)種、ラクトバチルス・パラカゼイ(Lactobacillus paracasei)種、ラクトバチルス・ファーメンタム(Lactobacillus fermentum)種、ラクトバチルス・ムコーサエ(Lactobacillus mucosae)種、ラクトバチルス・ロイテリー(Lactobacillus reuteri)種の1種もしくはそれらを複数種の菌体を混合したもの、または培養物を含む請求項1に記載の記憶・学習能維持および/または向上用組成物。 Heterofermentative Lactobacillus of the genus Lactobacillus is Lactobacillus harbinensis (Lactobacillus harbinensis) species, Lactobacillus rhamnosus species, Lactobacillus casei (Lactobacillus casei) Lactobacillus casei (Lactobacillus casei) , Lactobacillus fermentum species, Lactobacillus mucosae species, Lactobacillus reuteri species, or a mixture of multiple types of cells. The composition for maintaining and / or improving memory / learning ability according to claim 1.
  3. ラクトバチルス属のヘテロ発酵型乳酸桿菌が、ラクトバチルス・ハービネンシスSBT0796株、ラクトバチルス・ラムノーサスSBT2299株、ラクトバチルス・カゼイSBT2232株、ラクトバチルス・パラカゼイSBT0228株、ラクトバチルス・ファーメンタムSBT1859株、ラクトバチルス・ムコーサエSBT2958株、ラクトバチルス・ロイテリーSBT10010株の1株もしくはそれらを複数株の菌体を混合したもの、または培養物を含む請求項1に記載の記憶・学習能維持および/または向上用組成物。 Lactobacillus heterofermentative lactic acid rods are Lactobacillus herbinensis SBT0796 strain, Lactobacillus ramnosus SBT2299 strain, Lactobacillus casei SBT2232 strain, Lactobacillus paracasei SBT0228 strain, Lactobacillus fermentum SBT1859 strain, Lactobacillus fermentum SBT1859 strain. The composition for maintaining and / or improving memory / learning ability according to claim 1, which comprises one strain of Mukosae SBT2958 strain, one strain of Lactobacillus reutery SBT10010 strain, or a mixture of a plurality of strains of cells, or a culture.
  4. 請求項1から3のいずれかに記載の記憶・学習能維持および/または向上用組成物を含むことを特徴とする記憶・学習能維持および/または向上用食品、記憶・学習能維持および/または向上用医薬品、記憶・学習能維持および/または向上用飼料。 A food for maintaining and / or improving memory / learning ability, a food for maintaining / / maintaining memory / learning ability, and / or, which comprises the composition for maintaining and / or improving memory / learning ability according to any one of claims 1 to 3. Drugs for improving, memory / learning ability maintenance and / or feed for improvement.
  5. 受託番号がNITE BP-02993であるラクトバチルス・ハービネンシスSBT0796株、受託番号がNITE BP-02994であるラクトバチルス・ラムノーサスSBT2299株、又は受託番号がNITE BP-02997であるラクトバチルス・ロイテリーSBT10010株。 Lactobacillus harbinensis SBT0796 strain with a trust number of NITE BP-02993, Lactobacillus ramnosus SBT2299 strain with a trust number of NITE BP-02994, or Lactobacillus reutery SBT10010 strain with a trust number of NITE BP-02997.
PCT/JP2020/028687 2019-07-24 2020-07-27 Composition for maintaining and/or improving memory/learning ability, and food, medicine, and feed containing composition WO2021015289A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019-136269 2019-07-24
JP2019136269A JP6739603B1 (en) 2019-07-24 2019-07-24 Compositions for maintaining and/or improving memory/learning ability and foods, pharmaceuticals, feeds containing the compositions

Publications (1)

Publication Number Publication Date
WO2021015289A1 true WO2021015289A1 (en) 2021-01-28

Family

ID=71949336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/028687 WO2021015289A1 (en) 2019-07-24 2020-07-27 Composition for maintaining and/or improving memory/learning ability, and food, medicine, and feed containing composition

Country Status (3)

Country Link
JP (1) JP6739603B1 (en)
TW (1) TW202112387A (en)
WO (1) WO2021015289A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3196165A1 (en) * 2020-09-23 2022-03-31 Megmilk Snow Brand Co., Ltd. Muscle atrophy prevention agent
CN114098084A (en) * 2021-04-13 2022-03-01 中国人民解放军军事科学院军事医学研究院 Probiotic composition for relieving cognitive impairment caused by long-term low-dose radiation exposure and application thereof
CN115812968B (en) * 2022-11-17 2024-05-03 华南农业大学 Application of lactobacillus harbine in antioxidation, anti-aging and fat reduction

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0923848A (en) * 1995-07-14 1997-01-28 Calpis Food Ind Co Ltd:The Functional food having actions for improving cerebral function, reinforcing learning ability and increasing memorizing ability
KR20110057550A (en) * 2009-11-24 2011-06-01 일동제약주식회사 Product fermented by lactic acid bacteria effective to prevention and treatment of dementia, dementia-related disease and improvement of cognition impairment and preparation method and use thereof
JP2013005757A (en) * 2011-06-24 2013-01-10 Calpis Co Ltd Production method of casein-derived peptide by lactic acid fermentation
CN107455698A (en) * 2017-09-26 2017-12-12 大连大学 A kind of ocean polypeptide spy's dietary seafood for being used to promote intelligence development
US20180148801A1 (en) * 2016-11-29 2018-05-31 Wedea Inc. Composition for Preventing and Treating Degenerative Brain Disease Using Novel Lactic Acid Bacteria
WO2018129722A1 (en) * 2017-01-13 2018-07-19 Bened Biomedical Co., Ltd. A novel lactic acid bacteria and its applications
KR20190000450A (en) * 2017-06-23 2019-01-03 이대희 Food composition for improving learning and memory function comprising lactic acid bacteria, hericium erinaceus extract and ginkgo leaf extract
KR101937758B1 (en) * 2018-09-05 2019-01-11 마이크로바이오주식회사 Lactobacillus fermentum UBC-U32, and use thereof in prevention and treatment of neurodegenerative disease
CN109846044A (en) * 2019-01-31 2019-06-07 山东环亿生物科技有限公司 With improvement memory, the probiotic composition for improving immunity and preparation method thereof
JP2020026437A (en) * 2018-08-16 2020-02-20 葡萄王生技股▲ふん▼有限公司 Active substance of lactobacillus paracasei gks6, composition comprising the same and its use, for promoting longevity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5155961B2 (en) * 2009-07-17 2013-03-06 雪印メグミルク株式会社 Preventive, ameliorating, and therapeutic agents for metabolic disorders associated with aging
EP2863929B1 (en) * 2012-06-22 2016-07-20 Nestec S.A. Probiotic and polyphenol against neurodegeneration
KR101476236B1 (en) * 2012-08-16 2014-12-24 경희대학교 산학협력단 Lactobacillus having activity of preventing and/or treating aging and dementia
KR20170032815A (en) * 2015-09-15 2017-03-23 경희대학교 산학협력단 Novel lactic acid bacteria and composition for preventing, improving or treating neurodegenerative diseases or cognitive dysfunction
JPWO2017130859A1 (en) * 2016-01-28 2018-11-15 森永乳業株式会社 Nerve cell death inhibitor
CN116059257A (en) * 2016-05-31 2023-05-05 森永乳业株式会社 Brain function improving agent

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0923848A (en) * 1995-07-14 1997-01-28 Calpis Food Ind Co Ltd:The Functional food having actions for improving cerebral function, reinforcing learning ability and increasing memorizing ability
KR20110057550A (en) * 2009-11-24 2011-06-01 일동제약주식회사 Product fermented by lactic acid bacteria effective to prevention and treatment of dementia, dementia-related disease and improvement of cognition impairment and preparation method and use thereof
JP2013005757A (en) * 2011-06-24 2013-01-10 Calpis Co Ltd Production method of casein-derived peptide by lactic acid fermentation
US20180148801A1 (en) * 2016-11-29 2018-05-31 Wedea Inc. Composition for Preventing and Treating Degenerative Brain Disease Using Novel Lactic Acid Bacteria
WO2018129722A1 (en) * 2017-01-13 2018-07-19 Bened Biomedical Co., Ltd. A novel lactic acid bacteria and its applications
KR20190000450A (en) * 2017-06-23 2019-01-03 이대희 Food composition for improving learning and memory function comprising lactic acid bacteria, hericium erinaceus extract and ginkgo leaf extract
CN107455698A (en) * 2017-09-26 2017-12-12 大连大学 A kind of ocean polypeptide spy's dietary seafood for being used to promote intelligence development
JP2020026437A (en) * 2018-08-16 2020-02-20 葡萄王生技股▲ふん▼有限公司 Active substance of lactobacillus paracasei gks6, composition comprising the same and its use, for promoting longevity
KR101937758B1 (en) * 2018-09-05 2019-01-11 마이크로바이오주식회사 Lactobacillus fermentum UBC-U32, and use thereof in prevention and treatment of neurodegenerative disease
CN109846044A (en) * 2019-01-31 2019-06-07 山东环亿生物科技有限公司 With improvement memory, the probiotic composition for improving immunity and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BRAVO, J. A. ET AL.: "Ingestion of lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve", PROC. NATL. ACAD. SCI. USA, vol. 108, no. 38, 2011, pages 16050 - 16055, XP055492732, DOI: 10.1073/pnas.1102999108 *
CORPUZ, H. M. ET AL.: "Long-term administration of Lactobacillus paracasei K71 isolated from sake lees prevents cognitive decline in senescence- accelerated mouse prone-8", SAMP8, 2018, 5 March 2018 (2018-03-05), XP055787761, Retrieved from the Internet <URL:https://www.jsbba.or.jp/MeetingofJSBBA/2018/MeetingofJSBBA2018.pdf> [retrieved on 20200827] *
HUANG, S. Y. ET AL.: "Lactobacillus paracasei PS23 delays progression of age-related cognitive decline in senescence accelerated mouse prone 8 (SAMP8) mice", NUTRIENTS, vol. 10, no. 7, 2018, pages 1 - 13, XP055621946, DOI: 10.3390/nu10070894 *
NI, Y. ET AL.: "Lactobacillus and bitldobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota", MOL. NUTR. FOOD RES., vol. 63, no. 22, 25 September 2019 (2019-09-25), pages 1 - 14, XP055787711, DOI: 10.1002/mnfr.201900603 *
O'MAHONY, S. M. ET AL.: "A combination of dietary prebiotics and the probiotic LGG modulate behavioural and cognitive reponses to early life stress", NEUROGASTROENTEROL. MOTIL., vol. 28, 2016 *

Also Published As

Publication number Publication date
JP2021019507A (en) 2021-02-18
JP6739603B1 (en) 2020-08-12
TW202112387A (en) 2021-04-01

Similar Documents

Publication Publication Date Title
US10653730B2 (en) Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
AU2016324846B2 (en) Novel lactobacillus and composition for preventing, improving, or treating degenerative brain diseases or cognitive function disorders
WO2021015289A1 (en) Composition for maintaining and/or improving memory/learning ability, and food, medicine, and feed containing composition
AU2008257455B2 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
JP7038202B2 (en) New lactic acid bacteria and their uses
KR101779832B1 (en) Probiotic strains for use in improving the enteric nervous system
CN111935995A (en) Nutritional composition, and food and drink composition and formulated milk powder using the same
US11241463B2 (en) Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
US11058733B2 (en) Active substances of Bifidobacterium lactis GKK2, composition comprising the same and method of promoting longevity using the same
WO2021157435A1 (en) Sleep-promoting composition and foods, drugs, and feeds containing said composition
KR20210022221A (en) Bifidobacterium longum subsp. longum having both abilities of reducing total cholesterol in serum and immune regulation and its application
WO2021015288A1 (en) Composition for maintenance and/or improvement of memory/learning ability, and food, medicine and feed each containing said composition
JP2017171616A (en) MKP-1 inducer
US20230085298A1 (en) Sleep promoting composition, and food product, medicinal product, and animal feed containing said composition
JP2021020885A (en) Composition for maintaining and/or improving memory/learning ability, and food, medicine, and feed containing composition
JP2021019574A (en) Composition for maintaining and/or improving memory/learning ability, and food, pharmaceutical and animal feed containing the composition
JP2023023981A (en) LACTIC ACID BACTERIA FORMULATION FOR PROMOTING IN VIVO IgA AND IFN-γ PRODUCTION AND ORAL COMPOSITION
JP2021123562A (en) Sleep promoting composition and food, pharmaceutical, and feed containing composition
JP2021123561A (en) Sleep promoting composition and food, pharmaceutical, and feed containing composition
KR102579953B1 (en) Composition for preventing, treating or alleviating cognitive impairment comprising Lactococcus lactis subsp. Lactis LM1185 strain
JP2022117889A (en) Lactic acid bacteria having oxidative stress resistance imparting ability (il-8 inhibiting ability) and small intestinal stem cell gene regulating function

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20843491

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20843491

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP